GT Biopharma GTBP Cash Flow Statement (2010-2026)

NASDAQ GTBP
$0.29 +0.01 (+2.34%)
At close: Aug 21, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-4.38M-5.92M-18.19M-25.17M-220.01M-26.02M-114.70M-3.71M-3.83M-3.00M-2.95M-2.95M-3.80M-3.51M-115.89M-2.68M-26.88M-3.63M-18.48M-2.84M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
-0.01M0.29M0.30M0.11M0.00M0.10M0.12M0.01M0.00M0.00M0.38M0.05M0.05M
Gains from Investment Securities (Quarter)
-0.02M-0.01M-0.06M-0.04M-2.92M-1.39M-0.48M-0.00M-0.66M-0.12M-0.10M1.12M-0.13M0.11M-0.23M0.00M-0.01M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)
-4.29M-3.93M-3.71M-5.21M-2.79M-2.92M-4.30M-2.91M-1.89M-2.00M-2.05M-4.16M-3.54M-2.74M-2.47M-2.20M-3.01M-3.68M-4.00M-2.47M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M
Depreciation & Amortization (CF) (Quarter)
Change in Working Capital
Change in Receivables (Quarter)
Change in Inventory (Quarter)
Change in Accured Expenses (Quarter)
-0.01M-0.15M0.15M-0.84M-0.89M-3.53M3.23M-0.03M1.08M0.39M0.53M-1.35M0.12M1.00M1.17M-1.29M-0.33M-0.81M1.14M0.11M
Other Working Capital Changes (Quarter)
-0.01M-0.02M-0.03M-0.02M-0.03M-0.03M-0.03M-0.03M-0.03M
Investing Activities
Capital Expenditures (Quarter)
Sales of Property, Plant and Equipment (Quarter)
3.53M1.08M
Divestments (Quarter)
3.53M
Cash from Investing Activities (Quarter)
2.99M3.53M1.08M0.03M7.51M-6.99M2.66M1.84M0.48M5.03M7.86M-0.00M0.00M
Financing Activities
Other financing activities (Quarter)
16.24M0.14M0.62M0.44M4.44M0.58M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Short-Term Debt issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
0.13M0.12M0.11M0.11M0.40M0.60M0.60M
Net Equity Issued and Repurchased (Quarter)
6.27M0.62M4.83M1.06M4.00M4.00M
Dividend Payments
Dividends Paid - Common (Quarter)
0.14M
Misc.
Cash from Financing Activities (Quarter)
16.24M0.14M-0.00M6.27M0.62M5.88M0.98M8.30M4.58M
Change in Cash (Quarter)
11.95M-29.82M-0.71M-1.68M-1.93M-2.89M3.21M-3.63M0.72M-0.12M-1.57M0.87M7.30M-2.74M-2.47M-1.59M2.86M-2.70M4.28M2.11M
Free Cash Flow (Quarter)
-4.29M-3.93M-3.71M-5.21M-2.79M-2.92M-4.30M-2.91M-1.89M-2.00M-2.05M-4.16M-3.54M-2.74M-2.47M-2.20M-3.01M-3.68M-4.00M-2.47M
Net Cash Flow (Quarter)
11.95M-3.79M-0.71M-1.68M-1.71M-2.89M3.21M-3.63M0.76M-0.16M-1.57M0.87M4.32M-2.74M-2.47M-1.59M2.86M-2.71M4.30M2.11M